Nearly half of U.S. women ages 40–60 in a new national analysis reported at least one symptom associated with menopause during the previous 12 months. The figure is important, but it needs careful interpretation: it describes symptom reports in a population survey, not a diagnosis for every woman and not evidence that one treatment is right for everyone.

What the new report measured

The National Center for Health Statistics analyzed 2025 National Health Interview Survey responses from women ages 40–60 who were not currently pregnant, postpartum, or in surgical menopause. Participants were asked whether they had experienced symptoms commonly associated with menopause, including hot flashes, night sweats, sleep disturbance, irregular bleeding or menstrual cycles, and vaginal dryness.

Overall, 49.4% reported at least one of these symptoms in the past year. That estimate represents about 16.7 million U.S. women in the survey’s defined population.

Symptoms varied strongly by age

The proportion was lowest among women ages 40–43, at 23.9%. It rose to 48.1% at ages 44–47, 62.0% at ages 48–51, and 67.4% at ages 52–55. Among women ages 56–60, the figure declined to 53.1%.

This pattern is consistent with the fact that the menopausal transition does not happen on one birthday. Symptoms can begin before the final menstrual period, change over time, and continue after menopause. The survey captures that broad experience, but it does not establish when an individual woman entered a particular stage.

Most symptomatic women were not taking prescription medication

Among women who reported symptoms, 15.6% said they were currently taking a prescription medication for them. Prescription use was highest in the 52–55 age group, at 21.9%, and was 17.7% among women ages 56–60.

The report does not tell us why a woman did or did not use medication. Some symptoms may be mild, some women may prefer non-drug approaches, others may face access barriers, and some may have medical reasons that affect treatment choices. The survey also did not evaluate whether a specific treatment was effective.

Differences are descriptive, not explanations

Reported symptom prevalence varied by race and ethnicity, educational attainment, and urbanization. Those differences should not be treated as biological conclusions on their own. Access to care, language, cultural expectations, symptom recognition, work conditions, stress and other factors can affect whether symptoms are experienced, recognized or reported.

The study is cross-sectional. It can show how common reported symptoms were in 2025, but it cannot prove what caused the differences between groups.

When symptoms deserve medical attention

Hot flashes and sleep disturbance are common, but not every change in midlife should automatically be attributed to menopause. Heavy bleeding, bleeding after menopause, severe pelvic pain, persistent low mood, chest symptoms, or sleep problems that impair daily life warrant medical evaluation.

A clinician can review the pattern of menstrual changes, medications, pregnancy possibility, thyroid disease, anemia, sleep disorders and other conditions that may overlap with menopausal symptoms.

Treatment should be individualized

Management can include lifestyle adjustments, nonhormonal medicines, local treatments for genitourinary symptoms, or menopausal hormone therapy when appropriate. The balance of benefits and risks depends on the symptom being treated, age, time since menopause, personal and family medical history, and individual preferences.

Population statistics can normalize the experience and show that symptoms are common. They cannot replace a clinical conversation about what a particular woman is experiencing and what options fit her health profile.

The useful takeaway

The new data provide a clearer national snapshot: menopausal symptoms are common, peak in the early-to-mid 50s in this survey, and are not managed with prescription medication by most women who report them. The findings support better recognition and access to evidence-based care, while also reminding readers that symptom prevalence is not the same as diagnosis or treatment guidance.

This article is for general education and does not replace medical advice.